Mercado de dispositivos de artroscopia: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00020213
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 169
Buy Now

Se prevé que el mercado de dispositivos de artroscopia alcance los 9.853,88 millones de dólares en 2028, desde los 5.725,24 millones de dólares de 2021; se espera que registre una tasa compuesta anual del 8,1 % entre 2021 y 2028.

La artroscopia es un procedimiento para diagnosticar y tratar problemas articulares. Un cirujano inserta un tubo estrecho conectado a una cámara de video de fibra óptica llamada artroscopio a través de una pequeña incisión del tamaño de un ojal. Un artroscopio es un dispositivo médico que permite a los médicos ver el interior de las articulaciones del cuerpo, como la rodilla, la cadera, la columna, el hombro y el codo, para inspeccionar, diagnosticar y realizar procedimientos terapéuticos. Los dispositivos de artroscopia pueden examinar enfermedades como la osteoartritis, la artritis reumatoide, la tendinitis y los tumores óseos en las articulaciones.

El informe ofrece información y un análisis en profundidad del mercado de dispositivos de artroscopia enfatizando varios parámetros, como las tendencias del mercado, los avances tecnológicos y la dinámica del mercado. También proporciona el análisis del panorama competitivo de los principales actores del mercado en todo el mundo. Además, incluye el impacto de la pandemia de COVID-19 en el mercado en todas las regiones. La pandemia de COVID-19 creó a la vez una crisis de salud pública y una crisis económica en todo el mundo. Antes de la pandemia, el mercado mundial de dispositivos de artroscopia crecía constantemente a medida que se realizaban exámenes periódicos, consuelos y tratamientos. La primera ola de COVID-19 trastocó las consultas, seguimientos y despistajes de casos oncológicos. La situación de descontrol creada en el sector sanitario a nivel mundial, provocó la reducción del número de consultas y un menor número de casos diagnosticados de osteoartritis y artritis reumatoide. Varias empresas han experimentado graves pérdidas en el último trimestre de 2019; la pandemia también influyó negativamente en el primer y segundo trimestre de 2020. Por tanto, el impacto de la pandemia de COVID-19 en el mercado global fue inmediato y drástico. Las empresas en todo el mundo se vieron obstaculizadas debido a la interrupción de la cadena de suministro y al aumento de la demanda de productos y servicios sanitarios. Para reducir la infección por COVID-19 en hospitales y clínicas, los profesionales de la salud y los pacientes adoptaron y prefirieron el tratamiento remoto de los pacientes. En estas circunstancias imprevisibles, la práctica ortopédica no podía quedar indemne. Muchos tratamientos quirúrgicos y consultas no urgentes fueron cancelados o pospuestos. En muchas instituciones se suspendió la cirugía electiva y el volumen total de casos ortopédicos se redujo drásticamente para limitar la propagación del virus y reservar y reasignar recursos en personal sanitario (enfermeras, anestesiólogos), equipos médicos (equipos de protección personal, ventiladores), y camas. La estrategia de "quedarse en casa" en el mundo resultó en una reducción significativa de las cirugías de artroplastias y artroscopias, así como una disminución en la incidencia de casos de osteoartritis durante el período COVID-19.

Perspectivas estratégicas

A medida que la infraestructura sanitaria se vio afectada debido al brote de COVID-19 y la atención se centró en el tratamiento de la enfermedad, se descuidó el diagnóstico de diversas enfermedades. Además, la detección y el tratamiento de enfermedades musculoesqueléticas también se vieron obstaculizados por la pandemia de COVID-19. Esto limitó en gran medida el crecimiento del mercado de dispositivos de artroscopia en todo el mundo.  

regiones lucrativas para el mercado de dispositivos de artroscopia

Perspectivas del mercado
creciente prevalencia de trastornos musculoesqueléticos para impulsar el mercado

Los trastornos musculoesqueléticos (TME) son las afecciones de salud más comunes en todo el mundo. Según los datos publicados por la Organización Mundial de la Salud (OMS), en febrero de 2021, aproximadamente 1.710 millones de personas en todo el mundo padecían problemas musculoesqueléticos. El dolor lumbar es una afección musculoesquelética generalizada que afecta a 568 millones de personas en todo el mundo. El dolor lumbar es la principal causa de discapacidad en 160 países. Los trastornos musculoesqueléticos afectan gravemente la movilidad y la destreza, lo que provoca una jubilación anticipada del trabajo, una disminución del bienestar y una disminución de la capacidad de socializar. El número de personas discapacitadas por enfermedades musculoesqueléticas ha ido creciendo y se espera que esta tendencia continúe en las próximas décadas.

Además, según la OMS, los países de altos ingresos son los más afectados en términos de población. (441 millones), seguidos por los países de la Región del Pacífico Occidental de la OMS con 427 millones, mientras que el Sudeste Asiático tiene 369 millones. Las enfermedades musculoesqueléticas también son la principal causa de años vividos con discapacidad (AVD) en todo el mundo, y representan aproximadamente 149 millones de AVD, o el 17% de todos los AVD. Las fracturas, que afectan a 436 millones de personas en todo el mundo, la osteoartritis (343 millones), otras lesiones (305 millones), dolores de cuello (222 millones), amputaciones (175 millones) y artritis reumatoide (14 millones), contribuyen a la carga general. de enfermedades musculoesqueléticas.

La artroscopia quirúrgica es una opción terapéutica bien establecida para personas con dolor y disfunción articular crónica. En comparación con los procedimientos articulares abiertos, la artroscopia es menos invasiva y produce mejores resultados generales para el paciente en el tratamiento de los síntomas, la estancia hospitalaria, la recuperación estructural y los resultados a largo plazo. Por lo tanto, se espera que la creciente prevalencia de trastornos musculoesqueléticos, osteoartritis y artritis reumatoide impulse el mercado durante el período de pronóstico.

Información basada en el producto

Según el producto, los dispositivos de artroscopia El mercado se segmenta en artroscopios, implantes artroscópicos, sistemas de gestión de fluidos, sistemas de radiofrecuencia, sistemas de visualización, sistemas de afeitadoras eléctricas y otros equipos artroscópicos. En 2021, el segmento de artroscopios tuvo la mayor participación del mercado y se espera que registre la CAGR más rápida del 9,1% durante el período de pronóstico.  

Mercado de dispositivos de artroscopia, por producto: 2020 y 2028

Información basada en aplicaciones

Según la aplicación, el mercado de dispositivos de artroscopia se segmenta en artroscopia de rodilla, artroscopia de cadera, artroscopia de columna, pie y artroscopia de tobillo, artroscopia de hombro y codo, entre otras. En 2021, el segmento de artroscopia de cadera tuvo la mayor participación de mercado y se espera que registre la CAGR más alta del 8,9% durante 2021-2028.

Los actores del mercado de dispositivos de artroscopia adoptan estrategias orgánicas como el lanzamiento de productos y expansión para expandir su presencia y cartera de productos en todo el mundo y satisfacer las crecientes demandas.

Por geografía

Según la geografía, el mercado de dispositivos de artroscopia está segmentado en América del Norte (EE. UU., Canadá, y México), Europa (Reino Unido, Alemania, Francia, Italia, España y el resto de Europa), Asia Pacífico (China, Japón, India, Australia, Corea del Sur y el resto de Asia Pacífico), Medio Oriente y ; África (Emiratos Árabes Unidos, Arabia Saudita, Sudáfrica y el resto de Medio Oriente y África) y Sur y África. Centroamérica (Brasil, Argentina y el resto de América Central y del Sur).

Perfiles de empresas

  • Arthrex, Inc.
  • CONMED Corporation
  • Johnson and Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic
  • Richard Wolf GmbH.
  • Smith & Sobrino
  • Stryker Corporation
  • Zimmer Biomet
  • NuVasive, Inc.  
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is an arthroscopy device?

Arthroscopy is a procedure for diagnosing and treating joint problems. A surgeon inserts a narrow tube attached to a fiber-optic video camera through a small incision about the size of a buttonhole which is called an arthroscope. An arthroscope is a medical device that allows doctors to see within bodily joints such as the knee, hip, spine, shoulder, and elbow to inspect, diagnose, and perform therapeutic procedures. Arthroscopy devices can examine for illnesses like osteoarthritis, rheumatoid arthritis, tendinitis, and bone tumors in the joints.

What are the driving factors for the arthroscopy devices market across the globe?

Key factors that are driving the growth of this market are the growing prevalence of musculoskeletal disorders osteoarthritis and rheumatoid arthritis, rising number of sport injuries requiring arthroscopy procedure to prevent complete joint and rising elderly population. Additionally, the increasing prevalence of obesity and rising number of product launches and approvals are likely to emerge as a significant future trend in the market during the forecast period.

What is the market CAGR value of the arthroscopy devices market during the forecast period?

The CAGR value of the arthroscopy devices market during the forecasted period of 2021–2028 is 8.1%.

Which product led the arthroscopy devices market?

In 2021, the arthroscopes segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. The arthroscopes are primarily used in the minimally invasive strategy. It aids patients' recovery and reduces scarring. Moreover, the decrease in the life span of arthroscopes due to the sterilization process used to prevent contamination and the launch of single-use arthroscopes. Thus, due to above factors, the arthroscopes segment is expected to dominate the arthroscopy devices market by product segment. Moreover, arthroscopes are expected to register the highest CAGR in arthroscopy devices market during 2021-2028.

Which application held the largest share in the arthroscopy devices market?

In 2021, the hip arthroscopy held the largest share of the market, by application. The similar application segment of the arthroscopy devices market is expected to witness growth in its demand at the fastest CAGR from 2021 to 2028.

Who are the key players in the arthroscopy devices market?

The arthroscopy devices market majorly consists of players such as Arthrex, Inc.; CONMED Corporation; Johnson and Johnson Services, Inc.; KARL STORZ SE & Co. KG; Medtronic; Richard Wolf GmbH.; Smith & Nephew; Stryker Corporation; Zimmer Biomet; and NuVasive, Inc amongst others.

Which are the top companies that hold the market share in arthroscopy devices market?

Johnson and Johnson Services, Inc and CONMED Corporation are the top two companies that hold huge market shares in the arthroscopy devices market.

Which region is expected to witness significant demand for the arthroscopy devices market in the coming years?

The North America region secures the major share of the global arthroscopy devices market. Rapid increase in the number of arthroscopies in the region, advancements in arthroscopy products and the highly active research ecosystem for arthroscopic applications is projected to accelerate the growth of the market. Moreover, increasing prevalence of chronic diseases and orthopedic ailments, especially among the aging population in this region of arthroscopy devices is propelling the market's expansion in this region.

What is the COVID 19 impact on the arthroscopy devices market in the coming years?

Due to an increasing number of infected patients worldwide, several research institutes and leading organizations put an effort to develop efficient methods of COVID 19 treatment and ways to combat pandemic. Many companies manufacturing arthroscopy devices focused on responding emergencies by various strategies such as manufacturing PPEs to healthcare workers, distribution of pharmaceutical drugs and various other activities. For instance, in September 2020, Arthrex, a global leader in minimally invasive orthopedic technology, announced it is using its innovative production capabilities to manufacture and donate more than 6,000 protective face shields to school systems across the region.
According to World Health Organization (WHO). As the epidemic has become a global pandemic, many health authorities focused pandemic-related care and avoided human contact in reaction to growing transmission and strain on health-care resources by postponing elective surgeries, suspending outpatient clinics, and triaging employees involved in urgent care. For instance, as per the British Journal of Surgery published in May 2020 stated that orthopedic procedures would be affected most, with 6.3 million operations cancelled worldwide. Recent COVID-19 guidelines for pediatric orthopedic surgeons suggested focus on urgent care and triaging cases to postpone elective surgeries and clinic appointments, with transition to virtual-based care when appropriate.
Thus, the pandemic had a negative impact on the arthroscopy market in the region.

The List of Companies - Arthroscopy Devices Market

  1. Arthrex, Inc.          
  2. CONMED Corporation       
  3. Johnson and Johnson Services, Inc.             
  4. KARL STORZ SE & Co. KG                  
  5. Medtronic              
  6. Richard Wolf GmbH.          
  7. Smith & Nephew                
  8. Stryker Corporation           
  9. Zimmer Biomet    
  10. NuVasive, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports